Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics and Genomics, |
RCV001269940 | SCV001450308 | pathogenic | not provided | 2016-02-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003497919 | SCV004297563 | pathogenic | Familial hemophagocytic lymphohistiocytosis 3 | 2023-10-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys255Alafs*73) in the UNC13D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in UNC13D are known to be pathogenic (PMID: 14622600). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with clinical features of UNC13D-related conditions (PMID: 27408432, 33225392, 33746956). ClinVar contains an entry for this variant (Variation ID: 988529). For these reasons, this variant has been classified as Pathogenic. |